Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett’s carcinogenesis-Reference-Cited by-同舟云学术

Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett’s carcinogenesis

Published:2020-05 Issue:5 Volume:216 Page:152907
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Fassan Matteo,Realdon Stefano,Cascione Luciano,Hahne Jens C.,Munari Giada,Guzzardo Vincenza,Arcidiacono Diletta,Lampis Andrea,Brignola Stefano,Dal Santo Luca,Agostini Marco,Bracon Chiara,Maddalo Gemma,Scarpa Marco,Farinati Fabio,Zaninotto Giovanni,Valeri Nicola,Rugge Massimo

Funder

Italian Association for Cancer Research

Padua University

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference47 articles.

1. Trends in esophageal adenocarcinoma incidence and mortality;Hur;Cancer,2013

2. Cancer statistics, 2019;Siegel;CA Cancer J. Clin.,2019

3. The effect of endoscopic surveillance in patients with Barrett’s esophagus: a systematic review and meta-analysis;Codipilly;Gastroenterology,2018

4. Diagnosis and endoscopic management of Barrett’s esophagus: an Italian experts’ opinion based document;Costamagna;Dig. Liver Dis.,2017

5. ACG clinical guideline: diagnosis and management of Barrett’s esophagus;Shaheen;Am. J. Gastroenterol.,2016

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors;Molecular Oncology;2024-08-11

2. Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer;Clinical Cancer Research;2024-02-20

3. MiR-199a-5p Decreases Esophageal Cancer Cell Proliferation Partially through Repression of Jun-B;Cancers;2023-09-30

4. The role of mir-151a-5p in tumorigenesis; A systematic review;Pathology - Research and Practice;2023-09

5. miRNAs driving diagnosis, prognosis and progression in Merkel cell carcinoma;Pathology - Research and Practice;2023-09